Cargando…
ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma
The cross-talk between cancer cells and monocyte-derived alveolar macrophages (Mo-AMs) promotes non-small cell lung carcinoma (NSCLC) progression. In this study, we report that both cancer cells and Mo-AMs robustly express beta 3-adrenergic receptor (ADRB3) in NSCLC. ADRB3 supports lung cancer cells...
Autores principales: | Zheng, Meng, Zhou, Zhiling, Tian, Xiangting, Xiao, Dingzhang, Hou, Xinghua, Xie, Zhi, Liang, Haidan, Lin, Shuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568706/ https://www.ncbi.nlm.nih.gov/pubmed/32514619 http://dx.doi.org/10.1007/s00262-020-02627-3 |
Ejemplares similares
-
ADRB3 induces mobilization and inhibits differentiation of both breast cancer cells and myeloid-derived suppressor cells
por: Zhou, Zhiling, et al.
Publicado: (2022) -
ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling
por: Chen, Sijun, et al.
Publicado: (2023) -
Genetic Polymorphisms in ADRB2 and ADRB1 Are Associated with Differential Survival in Heart Failure Patients Taking β-Blockers
por: Guerra, Leonardo A., et al.
Publicado: (2022) -
DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
por: Zhou, Fang, et al.
Publicado: (2023) -
ADRB2-Targeting Therapies for Prostate Cancer
por: Kulik, George
Publicado: (2019)